In today's trading, some stocks from our universe of global marijuana-related stocks fared better than others. In alphabetical order by symbol, the 5 biggest marijuana stock gainers in trading on Thursday, April 6th, 2017 are as follows:
Abattis Bioceuticals Corp.
Shares of Abattis Bioceuticals (CSE:ATT)(OTC:ATTBF) closed today's trading up more than 23% without any recent news. To learn more about Abattis, be sure to check out the company's marijuana stock profile linked above.
Lexaria Biosciences Corp.
In today's trading, shares of Lexaria Biociences (CSE:LXX)(OTC:LXRP) were up nearly 15% without any recent news. Find custom charts and news regarding Lexaria by visiting their marijuana stock profile linked above.
Northsight Capital, Inc.
Today shares of Northsight Capital (OTC:NCAP) were up roughly 14% without any recent news. For custom charts and news regarding Northsight Capital, be sure to check out the company's marijuana stock profile linked above.
In today's trading, shares of Zynerba Pharmaceuticals (NASDAQ:ZYNE) finished up more than 6%without any recent news. For custom charts and news regarding Zynerba, be sure to check out the company's marijuana stock profile linked above.
To find more about any of today's marijuana stock gainers, check out their profile in our cannabis-related stock database via the linked ticker symbols above.
Keep up with cannabis stock and industry updates from the Daily Marijuana Observer by following us on social media and by subscribing to our email newsletter below.
Investing in nanocap, microcap, and small cap stocks is highly speculative. The publishers of DailyMarijuanaObserver.com are not registered as Investment Advisors or Broker-Dealers in any jurisdiction whatsoever. The information contained on DailyMarijuanaObserver.com (“this site”) has been prepared solely for informational purposes. Nothing on the site is an offer or solicitation to buy or sell securities. Investors should seek financial advice regarding the appropriateness of investing in any securities mentioned from their financial advisor.